Food gurus tout the benefits of eating spinach and kale, but some people are better off leaving them on the plate. A molecule in these leafy greens contributes to hyperoxaluria, a condition characterized by kidney stones at first and serious organ damage later.
Novome Biotechnologies is developing a gut microbiome treatment for hyperoxaluria. The company is engineering bacteria intended to populate the gut and then break down the key molecule before it causes problems. South San Francisco-based Novome now has $33 million in Series A financing to continue its research, which is expected to lead to tests in humans in about… Read more »
UNDERWRITERS AND PARTNERS
